| 1 |
35429966 | Therapeutic synergy of Triptolide and MDM2 inhibitor against acute myeloid leukemia through modulation of p53-dependent and -independent pathways. | 2022 Apr 16 |
1 |
| 2 |
26935527 | Triptolide sensitizes human breast cancer cells to tumor necrosis factor‑α‑induced apoptosis by inhibiting activation of the nuclear factor‑κB pathway. | 2016 Apr |
1 |
| 3 |
21904380 | MRx102, a triptolide derivative, has potent antileukemic activity in vitro and in a murine model of AML. | 2012 Mar |
1 |
| 4 |
22033489 | Activation of apoptosis signaling eliminates CD34+ progenitor cells in blast crisis CML independent of response to tyrosine kinase inhibitors. | 2012 Apr |
1 |
| 5 |
20691980 | Triptolide and TRAIL combination enhances apoptosis in cholangiocarcinoma. | 2010 Oct |
1 |
| 6 |
19383029 | Activity of triptolide against human mast cells harboring the kinase domain mutant KIT. | 2009 Jul |
1 |
| 7 |
18187663 | Triptolide sensitizes AML cells to TRAIL-induced apoptosis via decrease of XIAP and p53-mediated increase of DR5. | 2008 Apr 1 |
2 |
| 8 |
12826269 | Immunosuppressant PG490 (triptolide) induces apoptosis through the activation of caspase-3 and down-regulation of XIAP in U937 cells. | 2003 Jul 15 |
3 |